Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: The previously reported SANET-ep trial (NCT02588170) demonstrated surufatinib significantly improves progression-free survival (PFS) in patients (pts) with advanced extrapancreatic neuroendocrine tumors (epNETs) compared to placebo; median PFS (9.2 vs. 3.8 months; HR = 0.334, 95% CI 0.223 to 0.499, p<0.0001).
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Li J
Authors: Li J, Xu J, Zhou Z, Bai C, Chi Y,
Keywords: extra-pancreatic, neuroendocrine tumors, safety,
Introduction: A few previous studies have shown that nomograms can predict the survival rates of patients with neuroendocrine neoplasms (NENs).
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Wei W
Authors: Wei W, Cheng F, Jie C, Zhiwei Z, Ye C,
Keywords: Gastroenteropancreatic Neuroendocrine Neoplasms, Nomogram, Prognosis,
Introduction: The multicenter studies of large-volume database about gastroenteropancreatic neuroendocrine neoplasms(GEP-NENs) patients is rare in China.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Cheng F
Authors: Cheng F, Wei W, Zhiwei Z,
Keywords: gastroenteropancreatic neuroendocrine neoplasms, treatment, prognosis, China,
Introduction: Gastroenteropancreatic neuroendocrine neoplasms(GEP-NENs) are known to overexpress somatostatin receptors(SSTRs),which forms the basis for octreotide long-acting repeatable(LAR) treatment in NEN.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Jie C
Authors: Yuhong W, Wei W, Kaizhou J, Cheng F, Zhiwei Z,
Keywords: gastroenteropancreatic neuroendocrine neoplasm, somatostatin receptor, octreotide, treatment,